Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

News
Feb 2026
Knobbe Martens, Partners Shortlisted in Eight Categories for 2026 Managing IP Americas Awards
IRVINE, Calif., February 16, 2026 – Knobbe Martens is pleased to share that the firm and two of its partners have been shortlisted in eight categories for the 2026 Managing...
News
Mar 2026
Knobbe Martens Shortlisted in Multiple Categories for 2026 Life Sciences Patent Network Awards
IRVINE, Calif., March 5, 2026 – Highlighting its strength in the life sciences industry, Knobbe Martens is pleased to share that the firm is shortlisted in multiple categories for the...
Newsletter
Mar 2026
Litigation Update | February 2026
Result-Oriented Claims and Section 101: Claiming the How Daniel Kiang & Brandon Cormier Result-oriented claims were found ineligible under 35 U.S.C ? 101 because the claims did not describe how...